A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2011
11/17/2011	WO2011105900A3 Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
11/17/2011	WO2011074881A3 Substances for inhibiting expression of genes for sensitivity to allergic disorders
11/17/2011	WO2011059505A3 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
11/17/2011	WO2011006914A3 Antagonists, uses & methods for partially inhibiting tnfr1
11/17/2011	US20110282037 Antibody preparation
11/17/2011	US20110281932 Methods to enhance T-cell mediated immune response
11/17/2011	US20110281913 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
11/17/2011	US20110281909 Substituted quinoline derivatives as h1 receptor antagonists
11/17/2011	US20110281897 Heterocyclic compounds and their uses
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281866 Heterocyclic kinase inhibitors
11/17/2011	US20110281865 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281819 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280951 Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
11/17/2011	US20110280949 Microparticles for use in immunogenic compositions
11/17/2011	US20110280939 Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride
11/17/2011	US20110280934 Increased Expression of Specific Antigens
11/17/2011	US20110280930 Products and methods for stimulating an immune response
11/17/2011	US20110280913 Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders
11/17/2011	US20110280911 Cancer vaccine compositions and methods of using the same
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280906 Method for augmenting the immunogenicity of an antigen
11/17/2011	US20110280904 Generation of virus-like particles and use as panfilovirus vaccine
11/17/2011	US20110280903 Immunostimulatory combinations
11/17/2011	US20110280902 Compounds and methods for diagnosis and treatment of leishmaniasis
11/17/2011	US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
11/17/2011	US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes
11/17/2011	US20110280897 Polypeptides and uses thereof
11/17/2011	US20110280896 Methods and compositions for tumor vaccination and therapy
11/17/2011	US20110280895 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
11/17/2011	US20110280894 Her2/neu specific t cell receptors
11/17/2011	US20110280893 Synthetic lipid a derivative
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280881 Novel anti-hsp90 monoclonal antibody
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280872 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280869 Methods of preventing or treating inflammatory or autoimmune disorders by administering cd2 antagonists in combination with other prophylactic or therapeutic agents
11/17/2011	US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011	US20110280864 Low Viscosity Highly Concentrated Suspensions
11/17/2011	US20110280861 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion
11/17/2011	US20110280848 Composition comprising chicoric acid and/or derivatives thereof
11/17/2011	US20110280833 Peptides, derivatives and analogs thereof, and methods of using same
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280826 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2798932A1 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof
11/17/2011	CA2798328A1 Yeast cell wall components and detection thereof
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386317A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386316A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386315A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2087897B1 Method for producing apyrogenic immunomodulator
11/16/2011	EP1855692B1 Compositions for treating skin diseases characterised by exudation of serum proteins
11/16/2011	EP1646657B1 Antibodies to cd44 vra and methods of use
11/16/2011	EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
11/16/2011	CN1930160B Hiv integrase inhibitors
11/16/2011	CN1777415B Medicinal composition containing edible acid or its acid salt and its use
11/16/2011	CN102245638A Antibodies against IL-25
11/16/2011	CN102245602A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
11/16/2011	CN102245205A Methods to reduce B-helper T cells to treat autoimmune diseases
11/16/2011	CN102245198A IgE CH3 peptide vaccine
11/16/2011	CN102245187A Modulation of TOLL-like receptor 3 expression by antisense oligonucleotides
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof
11/16/2011	CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102242044A Cordyceps cicadae wine and preparation method thereof
11/16/2011	CN102242043A Bo beer blending liquor and preparation method thereof
11/16/2011	CN102242041A Maca rice wine and preparation method thereof
11/16/2011	CN102241785A Production technology of purslane polysaccharide
11/16/2011	CN102241710A Salidroside analogues as well as preparation method and application thereof
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102240365A Pharmaceutical composition for enhancing organism immunity and preparation method thereof
11/16/2011	CN102240331A Ointment mainly for treating rheumatoid arthritis
11/16/2011	CN102240307A Preparation method of ginkgo leaf extract
11/16/2011	CN102240304A Formulation for breeding sea cucumbers, shrimps or abalones
11/16/2011	CN102240300A Method for producing biologically active products
11/16/2011	CN102028829B Qi and middle tonifying Chinese medicinal composition and preparation method thereof
11/16/2011	CN101953949B Chinese medicinal composition for treating allergic rhinitis

1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1172